Anixa Biosciences Inc (ANIX)
2.85
-0.06
(-2.06%)
USD |
NASDAQ |
May 17, 16:00
2.86
+0.01
(+0.35%)
After-Hours: 20:00
Anixa Biosciences Total Liabilities (Quarterly): 1.768M for Jan. 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 1.768M |
| October 31, 2023 | 2.151M |
| July 31, 2023 | 1.993M |
| April 30, 2023 | 1.686M |
| January 31, 2023 | 1.394M |
| October 31, 2022 | 2.212M |
| July 31, 2022 | 1.656M |
| April 30, 2022 | 1.391M |
| January 31, 2022 | 1.996M |
| October 31, 2021 | 1.49M |
| July 31, 2021 | 1.208M |
| April 30, 2021 | 1.443M |
| January 31, 2021 | 1.526M |
| October 31, 2020 | 1.189M |
| July 31, 2020 | 1.224M |
| April 30, 2020 | 1.103M |
| January 31, 2020 | 1.166M |
| October 31, 2019 | 1.481M |
| July 31, 2019 | 1.444M |
| April 30, 2019 | 1.596M |
| January 31, 2019 | 1.327M |
| October 31, 2018 | 1.265M |
| July 31, 2018 | 1.130M |
| April 30, 2018 | 1.340M |
| January 31, 2018 | 1.087M |
| Date | Value |
|---|---|
| October 31, 2017 | 0.8895M |
| July 31, 2017 | 2.927M |
| April 30, 2017 | 3.66M |
| January 31, 2017 | 8.037M |
| October 31, 2016 | 4.641M |
| July 31, 2016 | 4.603M |
| April 30, 2016 | 4.646M |
| January 31, 2016 | 5.056M |
| October 31, 2015 | 4.282M |
| July 31, 2015 | 4.282M |
| April 30, 2015 | 4.143M |
| January 31, 2015 | 5.013M |
| October 31, 2014 | 5.046M |
| July 31, 2014 | 13.25M |
| April 30, 2014 | 15.35M |
| January 31, 2014 | 16.00M |
| October 31, 2013 | 8.760M |
| July 31, 2013 | 8.545M |
| April 30, 2013 | 8.800M |
| January 31, 2013 | 8.846M |
| October 31, 2012 | 6.855M |
| July 31, 2012 | 6.780M |
| April 30, 2012 | 7.133M |
| January 31, 2012 | 7.291M |
| October 31, 2011 | 7.588M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.103M
Minimum
Apr 2020
2.212M
Maximum
Oct 2022
1.554M
Average
1.481M
Median
Oct 2019
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.37M |
| Shareholders Equity (Quarterly) | 24.60M |